e-Brochure

PDF version of Cancer MSc

Contact details

Dr Julie Olszewski

Email: j.olszewski@ucl.ac.uk

Tel: +44 (0)20 7679 6911

Fees and funding

UK/EU 2013/14:

£12,250 (FT)

Overseas 2013/14:

£23,000 (FT)

Full details of funding opportunities can be found on the UCL Scholarships website

More information

Prospectus Entry

Cancer Institute

Key facts

Research Assessment Rating

75% rated 4* (world-leading) or 3* (internationally excellent)
(What is the RAE?)

The programme information on this page relates to 2013 entry. 2014 content to appear here shortly. 

Cancer MSc

The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.

Degree summary

What will I learn?

This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.

Why should I study this degree at UCL?

UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.

The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.

See subject website for more information:

Degree structure

Availability: Full-time 1 year

Students undertake modules to the value of 180 credits. The programme consists of two core modules (60 credits),four specialist modules (60 credits) and a research project (60 credits).

A Postgraduate Diploma (120 credits, full-time nine months or flexible study two years) is offered.

A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.

Core Modules

  • Basic Biology and Cancer Genetics
  • Cancer Therapeutics

Specialist Modules

  • Behavioural Science and Cancer
  • Biomarkers in Cancer
  • Cancer Clinical Trials
  • Haematological Malignancies and Gene Therapy

Dissertation/report

All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral presentation.

Teaching and Learning

Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written exam (50%) and coursework (50%). The research project is assessed by the dissertation (75%) and oral presentation (25%).

Further details available on subject website:

Entry and application

Entry requirements

A minimum of a second-class Bachelor's degree in a relevant discipline from a UK university or an overseas qualification of an equivalent standard.

For overseas equivalencies see the relevant country page.

How to apply

You may choose to apply online or download application materials; for details visit www.ucl.ac.uk/gradapps

The deadline for applications is 2 August 2013. Due to competition for places candidates are advised to apply as early as possible.

For those students working to organise scholarship funding (particularly overseas applicants), early application for admission is strongly encouraged, preferably by 1 March for the following academic year.

Who can apply?

The programme is designed for those with qualifications in life sciences, scientists, clinicians, and other healthcare professionals including individuals from the pharmaceutical and biotech industries. The knowledge and transferable skills developed are suitable for those in an industrial or healthcare setting, and for students contemplating further PhD or medical studies.

What are we looking for?

When we assess your application we would like to learn:

  • why you want to study this programme at graduate level
  • why you want to study this programme at UCL
  • what particularly attracts you to this programme
  • how your academic and professional background meets the demands of this programme
  • where you would like to go professionally with your degree
Together with essential academic requirements, the personal statement is your opportunity to illustrate whether your reasons for applying to this programme match what the programme will deliver.

Career

The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer. Examples of first destinations of recent graduates include:

  • Universities of Oxford, Cambridge and UCL: Full scholarship PhD studies:
  • Biomedical Publishing: Assistant Editor
  • Clinical Trials Assistant
  • Laboratory Technician

Find out more about London graduates' careers by visiting the Careers Group (University of London) website:


Request content update l Request printed information l Disclaimer
Page maintained by Publications and Marketing Services